UBRELVY
- Product NDC
- 85766-281
- Requested package NDC
- 85766-281-16
- 11-digit product format
- 857660281
- Labeler code
- 85766
- Product ID
- 85766-281_5c9c060b-9786-1c4d-e063-6294a90a788e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ubrogepant
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Sportpharm LLC
- Application
- NDA211765
- Marketing category
- NDA
- Marketing start
- 2019-12-23
- Substance
- UBROGEPANT
- Active strength
- 100 mg/1
- Pharmacologic classes
- Calcitonin Gene-related Peptide Receptor Antagonist [EPC], Calcitonin Gene-related Peptide Receptor Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N211765-001 | UBRELVY | UBROGEPANT | 50MG | TABLET / ORAL | RLD | 2019-12-23 | |
| N211765-002 | UBRELVY | UBROGEPANT | 100MG | TABLET / ORAL | RLD, RS | 2019-12-23 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N211765-001 | 9499545 | 2031-11-10 | U-2718 | Drug substance, Drug product | 2020-01-21 |
| N211765-001 | 9833448 | 2031-11-10 | U-2718 | 2020-01-21 | |
| N211765-001 | 8754096 | 2032-07-19 | U-2717 | Drug substance, Drug product | 2020-01-21 |
| N211765-001 | 8912210 | 2033-12-23 | Drug substance, Drug product | 2020-01-21 | |
| N211765-001 | 10117836 | 2035-01-30 | Drug product | 2020-01-21 | |
| N211765-001 | 11925709 | 2035-01-30 | Drug product | 2024-04-10 | |
| N211765-001 | 12168004 | 2035-01-30 | Drug product | 2025-01-15 | |
| N211765-001 | 12220408 | 2035-01-30 | Drug product | 2025-03-12 | |
| N211765-001 | 12310953 | 2035-01-30 | Drug product | 2025-06-25 | |
| N211765-001 | 12458632 | 2035-01-30 | Drug product | 2025-11-04 | |
| N211765-001 | 12458633 | 2035-01-30 | Drug product | 2025-11-04 | |
| N211765-001 | 11717515 | 2041-12-22 | U-3677 | 2023-09-07 | |
| N211765-001 | 11857542 | 2041-12-22 | U-3786 | 2024-01-31 | |
| N211765-001 | 12194030 | 2041-12-22 | U-4121 | 2025-02-11 | |
| N211765-001 | 12194030 | 2041-12-22 | U-4122 | 2025-02-11 | |
| N211765-001 | 12329750 | 2041-12-22 | U-4213 | 2025-07-16 | |
| N211765-002 | 9499545 | 2031-11-10 | U-2718 | Drug substance, Drug product | 2020-01-21 |
| N211765-002 | 9833448 | 2031-11-10 | U-2718 | 2020-01-21 | |
| N211765-002 | 8754096 | 2032-07-19 | U-2717 | Drug substance, Drug product | 2020-01-21 |
| N211765-002 | 8912210 | 2033-12-23 | Drug substance, Drug product | 2020-01-21 | |
| N211765-002 | 10117836 | 2035-01-30 | Drug product | 2020-01-21 | |
| N211765-002 | 11925709 | 2035-01-30 | Drug product | 2024-04-10 | |
| N211765-002 | 12168004 | 2035-01-30 | Drug product | 2025-01-15 | |
| N211765-002 | 12220408 | 2035-01-30 | Drug product | 2025-03-12 | |
| N211765-002 | 12310953 | 2035-01-30 | Drug product | 2025-06-25 | |
| N211765-002 | 12458632 | 2035-01-30 | Drug product | 2025-11-04 | |
| N211765-002 | 12458633 | 2035-01-30 | Drug product | 2025-11-04 | |
| N211765-002 | 12070450 | 2041-12-22 | U-3992 | 2024-09-25 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | N211765-001 | UBRELVY | 50MG | TABLET / ORAL | RLD | 2019-12-23 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N211765-002 | UBRELVY | 100MG | TABLET / ORAL | RLD, RS | 2019-12-23 | d4dbc9d85df4… | |
| 2026-10-15 13:18:30 | 2026-09 | N211765-001 | UBRELVY | 50MG | TABLET / ORAL | RLD | 2019-12-23 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N211765-002 | UBRELVY | 100MG | TABLET / ORAL | RLD, RS | 2019-12-23 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | N211765-001 | UBRELVY | 50MG | TABLET / ORAL | RLD | 2019-12-23 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N211765-002 | UBRELVY | 100MG | TABLET / ORAL | RLD, RS | 2019-12-23 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N211765-001 | UBRELVY | 50MG | TABLET / ORAL | RLD | 2019-12-23 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N211765-002 | UBRELVY | 100MG | TABLET / ORAL | RLD, RS | 2019-12-23 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N211765-001 | UBRELVY | 50MG | TABLET / ORAL | RLD | 2019-12-23 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N211765-002 | UBRELVY | 100MG | TABLET / ORAL | RLD, RS | 2019-12-23 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N211765-001 | UBRELVY | 50MG | TABLET / ORAL | RLD | 2019-12-23 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N211765-002 | UBRELVY | 100MG | TABLET / ORAL | RLD, RS | 2019-12-23 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N211765-001 | UBRELVY | 50MG | TABLET / ORAL | RLD | 2019-12-23 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N211765-002 | UBRELVY | 100MG | TABLET / ORAL | RLD, RS | 2019-12-23 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N211765-001 | UBRELVY | 50MG | TABLET / ORAL | RLD | 2019-12-23 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N211765-002 | UBRELVY | 100MG | TABLET / ORAL | RLD, RS | 2019-12-23 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N211765-001 | UBRELVY | 50MG | TABLET / ORAL | RLD | 2019-12-23 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N211765-002 | UBRELVY | 100MG | TABLET / ORAL | RLD, RS | 2019-12-23 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N211765-001 | UBRELVY | 50MG | TABLET / ORAL | RLD | 2019-12-23 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N211765-002 | UBRELVY | 100MG | TABLET / ORAL | RLD, RS | 2019-12-23 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N211765-001 | UBRELVY | 50MG | TABLET / ORAL | RLD | 2019-12-23 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N211765-002 | UBRELVY | 100MG | TABLET / ORAL | RLD, RS | 2019-12-23 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N211765-001 | UBRELVY | 50MG | TABLET / ORAL | RLD | 2019-12-23 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N211765-002 | UBRELVY | 100MG | TABLET / ORAL | RLD, RS | 2019-12-23 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N211765-001 | UBRELVY | 50MG | TABLET / ORAL | RLD | 2019-12-23 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N211765-002 | UBRELVY | 100MG | TABLET / ORAL | RLD, RS | 2019-12-23 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N211765-001 | UBRELVY | 50MG | TABLET / ORAL | RLD | 2019-12-23 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N211765-002 | UBRELVY | 100MG | TABLET / ORAL | RLD, RS | 2019-12-23 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N211765-001 | UBRELVY | 50MG | TABLET / ORAL | RLD | 2019-12-23 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N211765-002 | UBRELVY | 100MG | TABLET / ORAL | RLD, RS | 2019-12-23 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N211765-001 | UBRELVY | 50MG | TABLET / ORAL | RLD | 2019-12-23 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N211765-002 | UBRELVY | 100MG | TABLET / ORAL | RLD, RS | 2019-12-23 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N211765-001 | UBRELVY | 50MG | TABLET / ORAL | RLD | 2019-12-23 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N211765-002 | UBRELVY | 100MG | TABLET / ORAL | RLD, RS | 2019-12-23 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N211765-001 | UBRELVY | 50MG | TABLET / ORAL | RLD | 2019-12-23 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | N211765-002 | UBRELVY | 100MG | TABLET / ORAL | RLD, RS | 2019-12-23 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N211765-001 | UBRELVY | 50MG | TABLET / ORAL | RLD | 2019-12-23 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N211765-002 | UBRELVY | 100MG | TABLET / ORAL | RLD, RS | 2019-12-23 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N211765-001 | UBRELVY | 50MG | TABLET / ORAL | RLD | 2019-12-23 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | N211765-002 | UBRELVY | 100MG | TABLET / ORAL | RLD, RS | 2019-12-23 | 5d02ea3f76ae… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | N211765-001 | 9499545 | 2031-11-10 | U-2718 | Drug substance, Drug product | 2020-01-21 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N211765-001 | 9833448 | 2031-11-10 | U-2718 | 2020-01-21 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N211765-001 | 8754096 | 2032-07-19 | U-2717 | Drug substance, Drug product | 2020-01-21 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N211765-001 | 8912210 | 2033-12-23 | Drug substance, Drug product | 2020-01-21 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N211765-001 | 10117836 | 2035-01-30 | Drug product | 2020-01-21 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N211765-001 | 11925709 | 2035-01-30 | Drug product | 2024-04-10 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N211765-001 | 12168004 | 2035-01-30 | Drug product | 2025-01-15 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N211765-001 | 12220408 | 2035-01-30 | Drug product | 2025-03-12 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N211765-001 | 12310953 | 2035-01-30 | Drug product | 2025-06-25 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N211765-001 | 12458632 | 2035-01-30 | Drug product | 2025-11-04 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N211765-001 | 12458633 | 2035-01-30 | Drug product | 2025-11-04 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N211765-001 | 11717515 | 2041-12-22 | U-3677 | 2023-09-07 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N211765-001 | 11857542 | 2041-12-22 | U-3786 | 2024-01-31 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N211765-001 | 12194030 | 2041-12-22 | U-4121 | 2025-02-11 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N211765-001 | 12194030 | 2041-12-22 | U-4122 | 2025-02-11 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N211765-001 | 12329750 | 2041-12-22 | U-4213 | 2025-07-16 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N211765-002 | 9499545 | 2031-11-10 | U-2718 | Drug substance, Drug product | 2020-01-21 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N211765-002 | 9833448 | 2031-11-10 | U-2718 | 2020-01-21 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N211765-002 | 8754096 | 2032-07-19 | U-2717 | Drug substance, Drug product | 2020-01-21 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N211765-002 | 8912210 | 2033-12-23 | Drug substance, Drug product | 2020-01-21 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N211765-002 | 10117836 | 2035-01-30 | Drug product | 2020-01-21 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N211765-002 | 11925709 | 2035-01-30 | Drug product | 2024-04-10 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N211765-002 | 12168004 | 2035-01-30 | Drug product | 2025-01-15 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N211765-002 | 12220408 | 2035-01-30 | Drug product | 2025-03-12 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N211765-002 | 12310953 | 2035-01-30 | Drug product | 2025-06-25 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N211765-002 | 12458632 | 2035-01-30 | Drug product | 2025-11-04 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N211765-002 | 12458633 | 2035-01-30 | Drug product | 2025-11-04 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N211765-002 | 12070450 | 2041-12-22 | U-3992 | 2024-09-25 | d4dbc9d85df4… | |
| 2026-10-15 13:18:30 | 2026-09 | N211765-001 | 9499545 | 2031-11-10 | U-2718 | Drug substance, Drug product | 2020-01-21 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N211765-001 | 9833448 | 2031-11-10 | U-2718 | 2020-01-21 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N211765-001 | 8754096 | 2032-07-19 | U-2717 | Drug substance, Drug product | 2020-01-21 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N211765-001 | 8912210 | 2033-12-23 | Drug substance, Drug product | 2020-01-21 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N211765-001 | 10117836 | 2035-01-30 | Drug product | 2020-01-21 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N211765-001 | 11925709 | 2035-01-30 | Drug product | 2024-04-10 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N211765-001 | 12168004 | 2035-01-30 | Drug product | 2025-01-15 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N211765-001 | 12220408 | 2035-01-30 | Drug product | 2025-03-12 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N211765-001 | 12310953 | 2035-01-30 | Drug product | 2025-06-25 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N211765-001 | 12458632 | 2035-01-30 | Drug product | 2025-11-04 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N211765-001 | 12458633 | 2035-01-30 | Drug product | 2025-11-04 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N211765-001 | 11717515 | 2041-12-22 | U-3677 | 2023-09-07 | c2088c7a36db… |
Observed Orange Book exclusivity history#
| Captured | Edition | Application-product | Exclusivity code | Expiration | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N211765-001 | NCE | 2024-12-23 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N211765-002 | NCE | 2024-12-23 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N211765-001 | NCE | 2024-12-23 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N211765-002 | NCE | 2024-12-23 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N211765-001 | NCE | 2024-12-23 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N211765-002 | NCE | 2024-12-23 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N211765-001 | NCE | 2024-12-23 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N211765-002 | NCE | 2024-12-23 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | N211765-001 | NCE | 2024-12-23 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N211765-002 | NCE | 2024-12-23 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N211765-001 | NCE | 2024-12-23 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N211765-002 | NCE | 2024-12-23 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N211765-001 | NCE | 2024-12-23 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N211765-002 | NCE | 2024-12-23 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N211765-001 | NCE | 2024-12-23 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N211765-002 | NCE | 2024-12-23 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | N211765-001 | NCE | 2024-12-23 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | N211765-002 | NCE | 2024-12-23 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N211765-001 | NCE | 2024-12-23 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N211765-002 | NCE | 2024-12-23 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | N211765-001 | NCE | 2024-12-23 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | N211765-002 | NCE | 2024-12-23 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | N211765-001 | NCE | 2024-12-23 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | N211765-002 | NCE | 2024-12-23 | 4b0b4de00fa7… |
| 2022-03-09 01:35 UTC | 2022-03 | N211765-001 | NCE | 2024-12-23 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | N211765-002 | NCE | 2024-12-23 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | N211765-001 | NCE | 2024-12-23 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | N211765-002 | NCE | 2024-12-23 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N211765-001 | NCE | 2024-12-23 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N211765-002 | NCE | 2024-12-23 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | N211765-001 | NCE | 2024-12-23 | 5aa47cf7b7d7… |
| 2021-03-12 10:30 UTC | 2021-03 | N211765-002 | NCE | 2024-12-23 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | N211765-001 | NCE | 2024-12-23 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | N211765-002 | NCE | 2024-12-23 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | N211765-001 | NCE | 2024-12-23 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | N211765-002 | NCE | 2024-12-23 | c0c555d07b60… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N211765-001 | NCE | 2024-12-23 | 6a51e52b5d6a… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N211765-002 | NCE | 2024-12-23 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | N211765-001 | NCE | 2024-12-23 | 1c564ffb4f44… |
| 2024-02-18 07:12 UTC | 2024-02 | N211765-002 | NCE | 2024-12-23 | 1c564ffb4f44… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- UBRELVY
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| UBROGEPANT | 100 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| AD0O8X2QJR | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 36106b14-d410-4faf-a361-2871de8198c3 | Available on FDA.report |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| UBRELVY | UBROGEPANT | Sportpharm LLC | 36106b14-d410-4faf-a361-2871de8198c3 | 2026-09-29 | Warnings, Adverse reactions | 211765 NDA211765 85766-281-16 85766-281 85766028116 |
| UBRELVY | UBROGEPANT | Allergan, Inc. | fd9f9458-fd96-4688-be3f-f77b3d1af6ab | 2025-06-05 | Warnings, Adverse reactions | 211765 NDA211765 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 85766-281-16 | 85766028116 | 16 PACKET in 1 BOX (85766-281-16) / 1 TABLET in 1 PACKET | 16 packet | 2026-09-29 | No | No | Current |